Literature DB >> 1392420

Acquired protein S deficiency.

B Kemkes-Matthes1.   

Abstract

Hereditary deficiencies of coagulation inhibitors like antithrombin III, protein C and protein S lead to an enhanced incidence of thromboembolic complications. Recently, acquired deficiencies of protein S were described in several disease states in which thromboembolic complications frequently occur. These acquired protein S deficiencies reach--in part--the extent realised by hereditary protein S deficiency. Thus, acquired protein S deficiencies seem to be one source of thromboembolic complications occurring in nephrotic syndrome, acute phase reactions, malignancy and pregnancy. In this presentation disease states accompanied by acquired protein S deficiency and the mechanisms leading to these alterations are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392420     DOI: 10.1007/bf00210237

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  63 in total

1.  The effects of oestrogen administration on the plasma free protein S and C4b-binding protein.

Authors:  E Melissari; V V Kakkar
Journal:  Thromb Res       Date:  1988-03-01       Impact factor: 3.944

2.  Inactivation of factor VIII by activated protein C and protein S.

Authors:  F J Walker; S I Chavin; P J Fay
Journal:  Arch Biochem Biophys       Date:  1987-01       Impact factor: 4.013

3.  Deficiencies of protein C, an inhibitor of blood coagulation.

Authors:  P M Mannucci; S Vigano
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

Review 4.  Coumarin necrosis--a review of the literature.

Authors:  M S Cole; P K Minifee; F J Wolma
Journal:  Surgery       Date:  1988-03       Impact factor: 3.982

5.  Protein S deficiency occurs in the nephrotic syndrome.

Authors:  S Vigano-D'Angelo; A D'Angelo; C E Kaufman; C Sholer; C T Esmon; P C Comp
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

6.  Coagulation inhibitors in pulmonary cancer patients.

Authors:  B Kemkes-Matthes; T Plusczyk; H G Lasch
Journal:  Thromb Res       Date:  1992-01-01       Impact factor: 3.944

7.  Low protein S in essential thrombocythemia with thrombosis.

Authors:  M G Conlan; W D Haire
Journal:  Am J Hematol       Date:  1989-10       Impact factor: 10.047

8.  Enhanced thrombin generation in normal and hypertensive pregnancy.

Authors:  K de Boer; J W ten Cate; A Sturk; J J Borm; P E Treffers
Journal:  Am J Obstet Gynecol       Date:  1989-01       Impact factor: 8.661

9.  Functional and immunologic protein S in normal pregnant women and in full-term newborns.

Authors:  J A Fernández; A Estellés; J Gilabert; F España; J Aznar
Journal:  Thromb Haemost       Date:  1989-06-30       Impact factor: 5.249

10.  Deep venous thrombosis, inflammatory bowel disease, and protein S deficiency.

Authors:  E Wyshock; M Caldwell; J P Crowley
Journal:  Am J Clin Pathol       Date:  1988-11       Impact factor: 2.493

View more
  3 in total

Review 1.  The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis.

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Assessment of thrombophilic abnormalities during the active state of inflammatory bowel disease.

Authors:  Maha M Maher; Somaya H Soloma
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

Review 3.  Protein S: function, regulation, and clinical perspectives.

Authors:  Rinku Majumder; Tina Nguyen
Journal:  Curr Opin Hematol       Date:  2021-09-01       Impact factor: 3.218

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.